The American Society for Clinical Investigation seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve the health of all people. Read more about the ASCI
This session will be moderated by Anna Ryan Hemnes, MD, Associate Professor of Medicine at Vanderbilt University. Dr. Hemnes is Vice Chair of the ASCI Physician-Scientist Development Committee and Editor in Chief of Pulmonary Circulation.
Peter Tontonoz, MD, PhD, is the recipient of the ASCI’s 2022 Stanley J. Korsmeyer Award for his contributions to the understanding of the regulatory pathways of lipid metabolism and their effect on normal physiology and metabolic disease.
Diversity, Equity, and Inclusion Committee chair Sophie Paczesny, MD, PhD, and vice chair Sherita Golden, MD, MHS, summarize recent activities related to the committee, including the establishment of ASCI mid-career awards named for Dr. Marian W. Ropes and Dr. Louis W. Sullivan, the ASCI Perspectives video series (highlighted below), a call for volunteers to serve on the DEIC, and collection of member demographic information. If you have not yet completed the confidential Demographics area in your profile, we ask that you take a few minutes to do so now in support of the Society’s commitment to improving representation.
In this interview by DEIC member Dr. Patrick Nana-Sinkam (Virginia Commonwealth University), Dr. Charles S. Dela Cruz (Yale School of Medicine; elected 2022) discusses his history as a researcher and clinician, offers advice about finding a niche in both areas, and reflects on how the experience with COVID is influencing how the physician-scientist works.
From the JCI Editor: New Impact Factor and launch of Research Letters
On behalf of the Journal of Clinical Investigation’s Editorial Board, I am humbled by the opportunity to serve the ASCI and to have the privilege of determining the cutting-edge biomedical research published by the Journal. I am delighted to share with you that the JCI’s latest Journal Impact Factor (IF) is 19.456, representing a 24% increase from the previous year. Our sister journal, JCI Insight, has also increased its IF, which now stands at 9.484. This strong performance highlights the strength of our authors’ articles and reflects the importance of our mission to understand the basis of human disease. We are grateful to our authors for entrusting us with their work, to our reviewers and consulting editors for their dedication to maintaining the highest standards, and to the prior editorial team at Johns Hopkins for their expert leadership during the unprecedented challenges of the pandemic. These successes affirm the ASCI’s voice and the critical role of societies in the publishing landscape.
These new members come from 46 different institutions and represent excellence across the breadth of academic medicine. They were officially inducted into the Society at the ASCI Dinner and New Member Induction Ceremony, April 8, 2022, as part of the AAP/ASCI/APSA Joint Meeting at the Swissotel Chicago.